MohamedOOthmanMD

Advanced Endoscopic Interventional, Biliary Tract Disease, Pancreas Disease

Professor

Dr. Othman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7200 Cambridge St
Suite A10181
Houston, TX 77030
Phone+1 713-798-0950

Fax+1 713-798-8489

Dr. Mohamed Othman is a gastroenterologist in Houston, TX and is affiliated with multiple hospitals in the area, including Baylor St. Luke's Medical Center and Houston Methodist Hospital. He received his medical degree from Mansoura University Faculty of Medicine and has been in practice 18 years. He specializes in advanced endoscopic interventional, biliary tract disease, and pancreas disease. He has more than 100 publications and over 500 citings.

University of New Mexico School of MedicineFellowship, Gastroenterology, 2007 - 2010
University of New Mexico School of MedicineResidency, Internal Medicine, 2004 - 2007
Mansoura University Faculty of MedicineClass of 2001

Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD) Start of enrollment: 2016 Dec 12
Completed
ConMed Beamer Study Start of enrollment: 2021 May 27
Completed
Utility of OverStitch Sx After ESD Start of enrollment: 2020 Jul 02
Completed
Roles: Contact, Principal Investigator
Prospective Study FNB, Is It Time To Abandon Cytological Assessment Start of enrollment: 2021 Apr 09
Completed
Roles: Contact, Principal Investigator
Monopolar Current Cutting Knife vs Bipolar RFA Knife Start of enrollment: 2022 Jan 25
Active, not recruiting
Not Applicable
Roles: Principal Investigator, Contact
Hybrid Versus Non-Hybrid Endoscopic Submucosal Dissection for Colorectal Polyps (SHORT-ESD) Start of enrollment: 2022 May 09
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Traction vs. No Traction in Colonic ESD Start of enrollment: 2023 Dec 05
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

PubMed

Tu1409 RECTAL INDOMETHACIN DECREASE THE RISK OF POST-ERCP PANCREATITIS IN CONSECUTIVE PATIENTS. A TERTIARY REFERRAL CENTER EXPERIENCEMay 2018
Tu1409 RECTAL INDOMETHACIN DECREASE THE RISK OF POST-ERCP PANCREATITIS IN CONSECUTIVE PATIENTS. A TERTIARY REFERRAL CENTER EXPERIENCEMay 2018

6 Exocrine Pancreatic Insufficiency Symptoms That Can Cause GI TroubleMarch 23rd, 2022
Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)March 29th, 2021
Lifestyle Risk Factors, Quality of Life, and Intervention Preferences of Barrett’s Esophagus Patients: A Prospective Cohort StudyMarch 8th, 2021
Join now to see all